Australia  

Bharat Biotech inks deal with Washington varsity for intranasal COVID-19 vax

Mid-Day Wednesday, 23 September 2020
Leading vaccine maker Bharat Biotech on Wednesday announced a licensing agreement with Washington University School of Medicine in St. Louis for a novel chimp-adenovirus, single dose intranasal vaccine for Covid-19.

The Hyderabad-based company owns the rights to distribute the vaccine in all markets except USA, Japan and...
0
shares
ShareTweetSavePostSend
 

You Might Like


Related videos from verified sources

EJ Espresso: PM Modi & Rahul Gandhi in Bihar; Malaika's fitness mantra revealed [Video]

EJ Espresso: PM Modi & Rahul Gandhi in Bihar; Malaika's fitness mantra revealed

PM and Rahul to enter battleground Bihar today. Bharat Biotech's Covid vaccine cleared for Phase 3 trials. Eros Now apologises for 'vulgar' Navratri campaign. And Malaika's fitness mantra revealed as..

Credit: HT Digital Content     Duration: 05:11Published
Covid vaccine: Covaxin phase 3 trials on 3,000 people in UP, says minister [Video]

Covid vaccine: Covaxin phase 3 trials on 3,000 people in UP, says minister

Hyderabad-based pharma company Bharat Biotech to conduct phase 3 clinical trial tests in October. Uttar Pradesh Health Minister Jai Pratap Singh said around 3,000 people to be tested under the phase 3..

Credit: HT Digital Content     Duration: 02:29Published
Bharat Biotech will involve 3,000 people for phase-III trials of COVID vaccine in UP [Video]

Bharat Biotech will involve 3,000 people for phase-III trials of COVID vaccine in UP

Speaking on phase-III trials of the COVID-19 vaccine, Uttar Pradesh Health Minister Jai Pratap Singh on September 29 said Bharat Biotech will involve 3,000 people from the state- 1,500 each from..

Credit: ANI     Duration: 01:36Published

Tweets about this